Yahoo! JAPAN

2024/5/31 -Kelun-Biotech has established a complete innovative drug clinical research and operation platform under the protection of its electronic management system. The ...

2024/5/24 -KLUS Pharma is the US subsidiary of Kelun-Biotech, a China-based corporation with a broad pipeline targeting unmet needs in oncology and other serious diseases.

2024/5/23 -Merck and Kelun-Biotech revealed Phase 3 breast cancer data for the lead antibody-drug conjugate in their potentially $12 billion partnership.

3日前 -KELUNは石川県金沢市を中心に住宅,店舗設計,リノベーション,家具デザインを行う建築設計事務所です。 SS house 2024. Komatsu-City,Ishikawa (計画中)

2024/4/10 -Merck and Kelun-Biotech's antibody-drug conjugate achieved a 22% objective response rate and 80.5% disease control rate in heavily pretreated patients with ...

2024/5/31 -Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), a clinical-stage biotech company focused on biologic and small molecule ...

2024/5/21 -This will test the Kelun-originated anti-TROP2 ADC as maintenance after Keytruda plus chemo in first-line squamous NSCLC, and seeks to recruit 851 patients. It ...

2024/6/19 -... 非经营性-2020-0229 | 网站建设：中企动力成都 | 网站管理入口. Copyright @ 2012 kelun.com，All Rights Reserved | 友情链接：OKMAN官方网站. <. > 更多 · 抗击新冠.

2024/5/31 -Kelun-Biotech announced that A400/EP0031 has been granted Orphan Drug Designatio... · Orphan drugs are drugs used for the prevention, treatment and diagnosis of ...

2024/5/23 -Last December Kelun's first filing, for third-line triple-negative breast cancer, was accepted by China's regulator, and an ASCO abstract has just revealed the ...